Clinical trials

  • CICLOSPORIN for Takotsubo syndrome
  • TESTOSTERONE for Low ovarian reserve (according to Bologna criteria) | Androgen receptor polymorphism
  • BI 690517 for Chronic kidney disease
  • LVT-001 for COVID-19
  • EFTILAGIMOD ALFA for Metastatic breast cancer (HER2-negative/low)
  • trastuzumab deruxtecan for HER2-positive breast cancer | Brain metastases
  • Tarlatamab for Extensive-stage small cell lung cancer
  • OBEXELIMAB for Systemic Lupus Erythematosus
  • KETAMINE HYDROCHLORIDE for Aortic stenosis
  • IBERDOMIDE for Relapsed or refractory multiple myeloma
  • ILE-ALA-LEU-ILE-LEU-GLU-PRO-ILE-CYS-CYS-GLN-GLU-ARG-ALA-ALA-(DISCRETE-POLYETHYLENE GLYCOL)24 for Acute graft-versus-host disease (aGvHD)
  • TENOFOVIR ALAFENAMIDE for Chronic hepatitis B